Business
Why the Rhythm Biosciences (ASX:RHY) share price rocketed 28% to a record high
The Rhythm Biosciences Ltd (ASX: RHY) share price was an outstanding performer on Friday.
At one stage, the medical device company’s shares were up 28% to a record high of 95 cents.
The Rhythm Biosciences share price eventually ended the day 17.5% higher at 87 cents.
Why is the Rhythm Biosciences share price rocketing higher?
Investors were buying the company’s shares this week due to the release of a positive announcement.
Earlier this week, Rhythm Bioscience revealed that it has appointed France-based Biotem as the global manufacturer of its ColoSTAT test-kit.
Management advised that Biotem was chosen following a robust due diligence process to select a manufacturer for the product that could execute on its ambition to…
-
General14 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Noosa News16 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business14 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General16 hours agoToo skewed, too gentlemanly | The Spectator Australia